Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polypharmacy reduction and rationalization in schizophrenia
NL-OMON28592Not yet recruiting
- Sponsor
- A.Wunderink, Friesland Mental Health Services and University Center of Psychiatry, University Medical Center Groningen
- Start
- Jul 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of clozapine, haloperidol, sulpiride, aripiprazole and quetiapine, sponsored by A.Wunderink, Friesland Mental Health Services and University Center of Psychiatry, University Medical Center Groningen. Planned start Jul 2014; status: not yet recruiting.
02
Drugs
clozapinehaloperidolsulpiridearipiprazolequetiapine
Beyond the preview
Go deeper on NL-OMON28592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28592.